Skip to main content

Ipamorelin Therapeutic Application

Meaning

Ipamorelin Therapeutic Application refers to the clinical use of the selective growth hormone secretagogue (GHS) Ipamorelin to stimulate the body’s pulsatile release of endogenous Growth Hormone (GH). This pentapeptide is utilized to safely increase GH and subsequent Insulin-like Growth Factor 1 (IGF-1) levels, promoting anabolism, improving body composition, and enhancing sleep quality. Its application is specifically valued for its high selectivity for the GH receptor, which minimizes the release of other hormones like prolactin and cortisol, offering a favorable safety profile. It is a targeted strategy for hormonal revitalization.